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1. Introduction 
Membrane vesicles made of either pure phospho- 
lipids (liposomes) or phospholipids containing inserted 
glycolipids or glycoproteins, are used to introduce 
macromolecules into cells in culture [1 ] or whole 
animals [2]. However, since liposomes are mainly 
phagocytozed and not fused by living cells [3], they 
are very poor carriers. It appears that empty envelopes 
of fusogenic viruses uch as reconstituted envelopes 
of Sendai virus may be superior to liposomes as an 
efficient vehicle for macromolecules. Reconstituted 
Sendal virus envelopes (RSVE) fuse efficiently with 
plasma membranes of eucaryotic ells, thus delivering 
their content directly into the intraceUular space of 
the cells [4,5 ]. As the Sendal virions interact with 
exposed sialic acid residues, the vesicles are able to 
fuse with a wide range of cells [6]. This ability of 
Sendai virus is due to its F-glycoprotein [7]. It was 
therefore, of interest o purify this glycoprotein and 
to insert it into bilayers of phospholipids, with the 
hope that the vesicles formed would exhibit high 
fusogenic activity, the specificity of which may be 
dependent upon the addition of suitable binding pro- 
teins. Affinity chromatography or a combination 
of sieve chromatography and ion exchange columns 
have been used to purify Sendai virus F-glycoprotein 
from detergent-solubilized virus solution [8,9]. These 
methods, however, yield a low amount of biologically 
active glycoprotein due to many purification steps. 
Here we describe an efficient, simple and quick 
new method for obtaining high quantities of Sendai 
virus F-glycoprotein. The method involves reduction 
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of intact Sendai virus particles with dithiothreitol 
(DTT) and solubilization of the reduced virus with 
Triton X-100. Centrifugation of the detergent-solu- 
bilized virus yields a supernatant containing the 
F-glycoprotein as its main protein component. After 
removing the detergent from the supernatant, F-gly- 
coprotein containing vesicles were formed, which 
hemolyse human erythrocytes in the presence of the 
lectin wheat germ agglutinin (WGA). 
2. Materials and methods 
Sendai virus was isolated and its hemagglutination 
titer was determined as in [10]. F-glycoprotein was 
extracted from Sendai virus particles and membrane 
vesicles containing the F-glycoprotein were formed as 
in fig.1 and [11]. RSVE were prepared as in [11]. 
Human erythrocyte (type O ÷, aged 3 -6  weeks) were 
washed with solution A (150 mM NaC1, 20 mM Tris- 
HCI, pH 7.4) as in [10]. The erythrocytes (0.5 ml, 
2.5%, v/v) were incubated for 15 min at 4°c with 
50 gl of either RSVE (40-80/~g protein) or with 
F-glycoprotein containing vesicles (10-70/Jg protein; 
see legend to fig.4 or table i). After incubation in the 
cold, the reaction mixtures were transferred to 37°C. 
Wheat germ agglutinin was used to promote binding 
of F-glycoprotein containing vesicles to the erythro- 
cytes [8,9]: After 5 min of incubation at 37°C with 
gentle shaking, WGA (0.5-5 og/incubation mixture) 
was added and the suspension was allowed to incubate 
for another 25 rain at 37°C. 
Vesicle-cell fusion was terminated by the addition 
of 1.45 ml cold solution A. Hemolysis was deter- 
mined by evaluating the absorbance of the superna- 
tant at 540 nm, as before [10]. 
Antiserum against he Sendal virus envelope glyco- 
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INTACT SENDAl VIRUS (I0 mg protein/ml) 
DTT, 3 mM 
(in 1 ml of 150 mM NaCI, 20 mM Tris-HCl, pH 8.4) 
i 30 min, 37°C 
CENTRIFUGATION 
I00,000 xg, 30 min, 4°C~I I~ 
PELLET 
(resuspended in 1 ml of solution containin~ 
lO mg Triton X-IO0 and 150 mM NaCI, In ~I 
Tris-HCI, pH 7.4) 
1 20°C hour, 
CENTRIFU(~ATION 
lOO,O00 xg, 1 hour, 4°C ~ 
SUPERNATA2!T 
(a clear solution containing O.,q 
to 1.6 mg of the F-glycoprotein) 
÷ 
DIALYSIS 
(Spectrapor2tubes against Ig BSA in 1 l i te r  
I0 mM Tris-HCl, pH 7.4, 2 mM Ca ++ , 2 mM Mg ++ 
and NAN3, 2 raM) 
CENTRIFUGATION 





~ '~ PELLET 




(0.4 to 0.8 mg F-glycoprotein containing vesicles) 
Fig:l.A sehemesumm~ising ~e method ~robtaininghighly purified Send~ v~usF@ycoprotein(adapted wi h modifications 
~om [11]). 
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proteins was obtained from rabbit and used as in [ 12]. 
Gel electrophoresis was performed in 5-15% (w/v) 
of polyacrylamide linear gradient gels with 2.5% 
acrylamide as stacking el, using the discontinuous 
buffer system in [ 13]. At the end of the electropho- 
resis, the gels were stained by Coomassie blue and 
destained as in [14]. Protein was determined as in 
[151. 
3. Results 
Detergent treatment of Sendal virus particles 
resulted in solubilization of the two viral envelope 
glycoproteins, the hemagglutinin/neuraminidase (HN) 
and the fusion (F) protein [11 ]. These results how 
that if Sendai virus particles are reduced with DTT 
before solubllization with Triton X-100, only the 
F-glycoprotein is extracted into solution. On the other 
hand, the HN glycoprotein remains in the pellet as 
detergent-insoluble material. Fig.1 summarizes the 
experimental details for obtaining a detergent-solu- 
bilized Sendal virus F-glycoprotein. A highly purified 
Sendai virus F-glycoprotein s obtained only when 
the conditions detailed in fig.1 are followed. When 
lower concentrations of DTT or shorter incubation 
periods are used, different results are obtained, 
namely, both the HN and the F-glycoproteins are 
extracted into detergent-soluble fraction (fig.2A) 
[111. 
The results of fig.2 also show that during removal 
of the detergent, reoxidation of the reduced SH-groups 
of the F-glycoprotein takes place. It can be seen that 
after dialysis, in the absence of/3-mercaptoethanol, 
the F-glycoprotein migrates as a disulfide-linked com- 
plex F1,2 (fig.2C). However, when this F-glycoprotein 
is treated with iodoacetamide, r oxidation is prevented 
and the mobility of the F-glycoprotein s the same in 
the presence (fig.2B) and in the absence of/3-mercap- 
toethanol (not shown). In both cases the gels contain 
the two glycopeptides F1 and F2 in their reduced 
form (fig.2B). 
Removal of Triton X-100 from the soluble frac- 
tion results in the appearance of a turbid suspension 
which apparently consists of resealed membrane vesicles 
containing the F-glycoprotein as their main compo- 
nent. Incubation of these vesicles with intact human 
erythrocytes causes neither agglutination nor signifi- 
cant hemolysis at 4°C or 37°C (table 1). The negligible 
hemolysis that is observed in the absence of agglutina- 
tion, in the presence of these vesicles (table 1, fig.3), 
can be ascribed to the residual amount of Triton X-100 
which probably present in these membrane prepara- 
tions [ 16]. Hemolysis under these conditions was 
Table 1 
Induction of hemolysis n human erythrocytes by membrane 
vesicles containing biologically active F-glycoprotein 
Treatment ofFICOn- Addition Hemolysis 
taining vesicles of WGA (% of total) a 
A B C 
HN i ..... I rt, 2 
r, - .  
Fig.2. Gel electrophoretic analysis of Sendai virus F-glyco- 
protein in 5-15% (w/v) polyacrylamide g ls: (A) 80 #g 
RSVE were loaded on the gel after boiling in 100 ~1 5% SDS 
and 2% ~3-mercaptoethanol; (B) 60 ~tg F-glycoprotein - other 
experimental conditions as in (A) and section 2; (C) as in (B) 
but in the absence of t3-mercaptoethanol (the2% SDS solu- 
tion did not contain ~3-mercaptoethanol). 
None - 2- 5 
None + 50-60 
Antiviral antiserum + 2- 5 
Trypsin + 2- 5 
PMSF (10 mM) + 0 
DTT (10 mM) + 2 5 
0°C, 6 h + 2- 5 
a The data axe the mean of 5 expts 
F-Glycoprotein containing vesicles (40 ~g/system) were 
incubated with human erythrocytes inthe presence or 
absence of WGA (1/ag/system) asin section 2. For trypsini- 
zation or for reduction, 100 #g in 95 ~g of F-glycoprotein 
vesicles were incubated with either 5 ~1 trypsin (1 mg/ml) 
or 5 gl DTT (200 mM), respectively, in solution A, adjusted 
to pH 8.4, for 2.5 h at 37°C. Proteolysis was stopped by 
30 ~g soybean trypsin inhibitor and reduction was terminated 
by 15 tal 200 mM iodo-acetamide. Treatment with PMSF was 
performed essentially as described for DTT, except hat it 
was performed in solution A at pH 7.4. After 2.5 h at 37°C, 
alkylation of the F-glycoprotein was stopped by the addition 
of 15 ~1 solution containing 100 mM serine 
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Fig.3. The effect of increasing concentrations ofWGA on 
the degree of hemolysis of human erythrocytes in the presence 
of F-glycoprotein containing vesicles. Increasing amounts 
of WGA were added to a mixture containing 0.5 ml human 
erythrocytes (2.5%, v/v) and 50 ug F-glycoprotein containing 
vesicles. All other experimental conditions were as in section 2. 
more, treatment of the vesicles with trypsin, phenyl-  
methyl-sulfonyl fluoride (PMSF) (10 raM) and DTT 
(10 raM) causes inactivation of their hemolytic activity 
(table 1). Induction of hemolysis requires relatively 
high temperature (37°C). Incubation of the vesicles 
with erythrocytes in the cold, even for a long period 
(6 h), did not result in measurable hemolysis (table 1). 
These findings clearly prove that the presence of 
biologically active F-glycoprotein is necessary for the 
induction of hemolysis under the present experi- 
mental conditions. The same treatment that blocks 
hemolysis by the F-glycoprotein containing vesicles, 
prevented induction of hemolysis but not of aggluti- 
nation by intact Sendal virus particles or by RSVE 
[7] (M. T., A. L., unpublished). 
~<5%. Interestingly, addition at 37°C of the lectin 
WGA to a mixture of F-glycoprotein containing 
vesicles and human erythrocytes promptly induces 
agglutination. When the agglutinated erythrocytes are 
allowed to incubate at 37°C for a certain time, hemo- 
lysis is induced (table 1), the extent of which was 
dependent upon the time of incubation and the con- 
centrations of both lectin (fig.3) and the F-glycopro- 
tein (fig.4). 
Optimal hemolysis is obtained when 1-3 ~tg WGA 
are added/system. At higher concentrations of WGA, 
agglutination is increased but, conversely, hemolysis 
is significantly reduced (fig.3). Hemolysis is absolutely 
dependent on the presence of the viral F-glycopro- 
rein, as is apparent from the results summarized in 
table 1 and fig.4. 
Antiviral antibody completely blocks hemolysis 
induced by the F-glycoprotein containing vesicles 
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Fig.4. Hemolysis as a function of F-glycoprotein concentra- 
tion. WGA (2/~g) was added to a mixture of human erythro- 
cytes and increasing amounts of F-glycoprotein containing 
vesicles, as in section 2. 
4. D iscuss ion 
This work describes a new and quick way, without 
the use of chromatography, to obtain biologically 
active F-glycoprotein of Sendal virus in a highly 
purified form. The method is based on the observa- 
tion that solubilization with Triton X-100 of Sendal 
virus particles which were first reduced with DTT, 
leads to the extraction of the F-glycoprotein but not 
of the viral HN glycoprotein. Since without treatment 
with DTT an unreduced HN is recovered in the Triton- 
solubilized fraction [11 ], it may be inferred that 
reduction with DTT induces drastic conformational 
changes rendering this protein detergent-insoluble. 
The reduced HN glycoprotein probably forms large 
aggregates caused by protein protein interactions 
prevented in the native unreduced glycoprotein. The 
view that reduction induces conformational changes 
in the HN protein, is strengthened by observations 
[ 17,18 ] showing that treatment with DTT completely 
blocked the biological activity of the HN, namely, 
agglutination of cells both at 4°C and at 37°C. 
There are convincing indications that the biological 
function of the viral F-glycoprotein is to promote 
fusion between the viral envelope and the plasma 
membrane of recipient cells [6]. This assumption was 
confirmed by experiments where F-glycoprotein con- 
taining liposomes were shown tct induce hemolysis of 
human erythrocytes at 37°C [8,9]. However, lysis 
was induced only in the presence of WGA which 
probably mediates binding of these vesicles to recipi- 
ent cell surfaces [8,9]. This is understandable, as 
F-vesicles lack the viral native binding protein, i.e., 
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the HN glycoprotein. Lysis by viral particles is 
assumed to reflect a process of virus-cell fusion [20]. 
Membrane vesicles containing the F-glycoprotein 
obtained by this method exhibit essentially the same 
characteristics a  the F-glycoprotein obtained by 
either affinity or sieve chromatography methods 
I8,9]. 
Therefore, it may be assumed that in the presence 
of WGA, the F-containing vesicles readily fuse with 
plasma membranes. Further studies with F-contain- 
ing vesicles are required to prove this point. 
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